|
Market Closed -
Euronext Paris
11:55:00 2026-09-07 EDT
|
5-day change | 1st Jan Change | ||
| 2.420 EUR | 0.00% |
|
+3.42% | -19.33% |
| 08-10 | ABL Diagnostics Plans Listing Transfer to Euronext Growth Paris | MT |
| 07-23 | French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 45.19M | - | - | - | - | - |
| 187B | |||||
| 120B | |||||
| 63.15B | |||||
| 51.75B | |||||
| 50.32B |
- Stock Market
- Stocks
- ABLD Stock
- Charts ABL Diagnostics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
